Product revenues, net

Name: Vertex Pharmaceuticals Product revenues, net by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Vertex Pharmaceuticals·Products & Services·8 segments·Rolls up to Total Revenue

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
TRIKAFTA/KAFTRIO	$2.45B	$2.59B	$2.72B	$2.54B	$2.55B	$2.65B	$2.57B	$2.35B
ALYFTREK	—	—	—	$53.90M	$156.80M	$247.00M	$380.10M	$424.40M
Other CF product revenues	—	$186.90M	$191.20M	$155.30M	$236.10M	$175.80M	$237.40M	$135.90M
CASGEVY	$0.00	$2.00M	$8.00M	$14.20M	$30.40M	$16.90M	$54.30M	$42.90M
JOURNAVX	—	—	—	—	$12.00M	$19.60M	$26.70M	$29.00M
Total	$2.65B	$2.77B	$2.91B	$2.77B	$2.96B	$3.08B	$3.19B	$2.99B

Product revenues, netView metric

Other revenuesView metric

TRIKAFTA/KAFTRIOView metric

Other CF product revenuesView metric

Total CF product revenues, netView metric

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
TRIKAFTA/KAFTRIO	$2.45B	$2.59B	$2.72B	$2.54B	$2.55B	$2.65B	$2.57B	$2.35B
ALYFTREK	—	—	—	$53.90M	$156.80M	$247.00M	$380.10M	$424.40M
Other CF product revenues	—	$186.90M	$191.20M	$155.30M	$236.10M	$175.80M	$237.40M	$135.90M
CASGEVY	$0.00	$2.00M	$8.00M	$14.20M	$30.40M	$16.90M	$54.30M	$42.90M
JOURNAVX	—	—	—	—	$12.00M	$19.60M	$26.70M	$29.00M
Total	$2.65B	$2.77B	$2.91B	$2.77B	$2.96B	$3.08B	$3.19B	$2.99B